Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-04-26
DOI
10.3389/fimmu.2017.00458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
- (2016) Y. Mao et al. BLOOD
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- (2016) Jun-ichi Masuyama et al. CYTOTHERAPY
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
- (2016) Monique M. van Ostaijen-ten Dam et al. JOURNAL OF IMMUNOTHERAPY
- IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis
- (2016) S Venkatasubramanian et al. Mucosal Immunology
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Manufacturing Natural Killer Cells as Medicinal Products
- (2016) Christian Chabannon et al. Frontiers in Immunology
- Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help
- (2016) Jing Ni et al. OncoImmunology
- Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma
- (2016) Markus Granzin et al. OncoImmunology
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The off-target effects of nonspecific NK cells
- (2015) D. A. Lee BLOOD
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
- (2015) Gerharda H. Boerman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role of IL-21 in immunity and cancer
- (2015) Matthew R. Davis et al. CANCER LETTERS
- Umbilical cord blood–derived cellular products for cancer immunotherapy
- (2015) Jeannette Cany et al. CYTOTHERAPY
- Challenges of cancer therapy with natural killer cells
- (2015) Hans Klingemann CYTOTHERAPY
- Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
- (2015) Markus Granzin et al. CYTOTHERAPY
- Multiple effects of IL-21 on human NK cells in ex vivo expansion
- (2015) Qi Li et al. IMMUNOBIOLOGY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Human Cytokine-Induced Memory-Like Natural Killer Cells
- (2015) Melissa M. Berrien-Elliott et al. Journal of Innate Immunity
- Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
- (2015) Naoyuki Sakamoto et al. Journal of Translational Medicine
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
- (2015) Kathrin Meinhardt et al. OncoImmunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
- (2015) Panagiotis D. Kottaridis et al. PLoS One
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
- (2014) E. Schlecker et al. CANCER RESEARCH
- Effect of exposure to interleukin-21 at various time points on human natural killer cell culture
- (2014) Dong-Pyo Lim et al. CYTOTHERAPY
- Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
- (2014) K. Stringaris et al. HAEMATOLOGICA
- IL-12–producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion
- (2014) Alexander Rölle et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
- (2014) Cristina Eguizabal et al. Frontiers in Immunology
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy
- (2013) S. A. Lim et al. CANCER RESEARCH
- Ex Vivo Activation of CD56+ Immune Cells That Eradicate Neuroblastoma
- (2013) P. Rujkijyanont et al. CANCER RESEARCH
- Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture
- (2013) Michael Apel et al. CHEMIE INGENIEUR TECHNIK
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers
- (2013) Eun-Kyung Kim et al. CYTOTHERAPY
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
- (2013) G. Peruzzi et al. JOURNAL OF IMMUNOLOGY
- Neuroblastoma-Derived TGF- 1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
- (2013) R. Castriconi et al. JOURNAL OF IMMUNOLOGY
- ADAM17-Mediated Shedding of Fc RIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation
- (2013) L. Lajoie et al. JOURNAL OF IMMUNOLOGY
- Irradiated and Activated Autologous PBMCs Induce Expansion of Highly Cytotoxic Human NK Cells In Vitro
- (2013) Yong-Oon Ahn et al. JOURNAL OF IMMUNOTHERAPY
- GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
- (2013) Okjae Lim et al. PLoS One
- Bringing natural killer cells to the clinic: ex vivo manipulation
- (2013) R. W. Childs et al. Hematology-American Society of Hematology Education Program
- New prospects on the NKG2D/NKG2DL system for oncology
- (2013) Evelyn Ullrich et al. OncoImmunology
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Membrane-bound interleukin-21 and CD137 ligand induce functional human natural killer cells from peripheral blood mononuclear cells through STAT-3 activation
- (2012) X. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
- (2012) T. K. Garg et al. HAEMATOLOGICA
- Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cells
- (2012) Xuewen Deng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products
- (2012) Robert Skeate et al. TRANSFUSION
- Successful “in-flight” activation of natural killer cells during long-distance shipping
- (2012) Scott A. Koepsell et al. TRANSFUSION
- Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions
- (2012) Hans Klingemann et al. TRANSFUSION
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Ex vivo expansion of natural killer cells: a question of function
- (2011) Tolga Sutlu et al. CYTOTHERAPY
- Leukemic Priming of Resting NK Cells Is Killer Ig-like Receptor Independent but Requires CD15-Mediated CD2 Ligation and Natural Cytotoxicity Receptors
- (2011) M. Sabry et al. JOURNAL OF IMMUNOLOGY
- Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
- (2011) Hua Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study
- (2011) Claudia Brehm et al. PLoS One
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Allogeneic natural killer cells for refractory lymphoma
- (2010) Veronika Bachanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
- (2010) Eleni G. Iliopoulou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
- (2010) O. Ashiru et al. CANCER RESEARCH
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
- (2010) Uwe Siegler et al. CYTOTHERAPY
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
- (2010) Stephan Kloess et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
- (2010) Lola Fernández-Messina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gene Expression Analysis of Ex Vivo Expanded and Freshly Isolated NK Cells From Cancer Patients
- (2010) Kyoung Un Park et al. JOURNAL OF IMMUNOTHERAPY
- IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion
- (2010) Sabine Huenecke et al. JOURNAL OF IMMUNOTHERAPY
- IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication
- (2010) Alexandre Iannello et al. JOURNAL OF LEUKOCYTE BIOLOGY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Pluripotent stem cell-derived natural killer cells for cancer therapy
- (2010) David A. Knorr et al. Translational Research
- IL-21 augments natural killer effector functions in chronically HIV-infected individuals
- (2009) Natasa Strbo et al. AIDS
- Replicative potential of human natural killer cells
- (2009) Hiroyuki Fujisaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products
- (2009) S. Schüle et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia
- (2009) Andrea Velardi et al. CURRENT OPINION IN IMMUNOLOGY
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Safety analysis ofex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
- (2009) Lisbeth Barkholt et al. Immunotherapy
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
- (2008) E. Alici et al. BLOOD
- Human Leukocyte Antigen-G and Cancer Immunoediting
- (2008) M. Urosevic et al. CANCER RESEARCH
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation
- (2008) Sandrine Meyer-Monard et al. TRANSFUSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now